Generic Name and Formulations:
Haemophilus b conjugate 7.5mcg (meningococcal protein conjugate 250mcg); per 0.5mL; IM inj.
Merck & Co., Inc.
Indications for PEDVAXHIB:
Immunization of children against H. influenzae type b.
<2 months: not recommended. 2 and 4 months: 0.5mL lM. Children vaccinated (with 2 dose regimen) before 12 months should receive booster at 12 months (but not <2 months after previous shot). Previously unvaccinated children, 15–71 months: 0.5mL lM once.
Immunodeficiency. Delay administration in febrile or active infection. Have epinephrine inj (1:1000) available. Protection begins several days after injection. Pregnancy (Cat. C): not recommended.
Local reactions, fever.
Single-dose vials (w. diluent)—10
Endocrinology Advisor Articles
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- AAP Shares List of 5 Unnecessary Pediatric Tests and Procedures
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents
- High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
- Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients
- Optimal Timing of Gastric Bypass and Cholecystectomy When Both Procedures Clinically Indicated
- Does Asthma Contribute to Infertility?
- Short-Term Probiotics Increase Weight Loss in Overweight, Obesity